Levamfetamine
As of the edition of 20 October 2026, Levamfetamine is a small molecule: withdrawn from the market in 1973; acts on SLC18A2, SLC6A2 and SLC6A3.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Withdrawn from market, 1973
- Kind
- Small molecule
- Withdrawn from market
- 1 January 1973 (in some regions)
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.